InMed Pharmaceuticals (INM) Other Operating Expenses (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Other Operating Expenses of $74875.0 for Q1 2026, up 1.36% year-over-year from $73871.0 in Q1 2025, and up 113.53% quarter-over-quarter from $35065.0 in Q4 2025.
InMed Pharmaceuticals (INM) Other Operating Expenses (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $74875.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 1.36% year-over-year to $74875.0; the TTM figure through Mar 2026 stood at $252549.0 (down 5.34% YoY), while the FY2025 annual figure was $241310.0, up 20.05% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $74875.0, up from $35065.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $3.5 million in Q2 2022, with the low at -$2.9 million in Q2 2023.
- The 5-year median for Other Operating Expenses is $74875.0 (2026), against an average of $188996.6.
- Peak annual rise in Other Operating Expenses reached 1552.36% in 2023, while the deepest fall reached 182.37% in 2023.
- InMed Pharmaceuticals' Other Operating Expenses stood at $809530.0 in 2022, then tumbled by 101.83% to -$14798.0 in 2023, then surged by 782.22% to $100955.0 in 2024, then slumped by 65.27% to $35065.0 in 2025, then soared by 113.53% to $74875.0 in 2026.
- Business Quant data shows INM's Other Operating Expenses at $74875.0 in Q1 2026, $35065.0 in Q4 2025, and $110196.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,875.00 |
| Dec 31, 2025 | 35,065.00 |
| Sep 30, 2025 | 110,196.00 |
| Jun 30, 2025 | 32,413.00 |
| Mar 31, 2025 | 73,871.00 |
| Dec 31, 2024 | 100,955.00 |
| Sep 30, 2024 | 35,269.00 |
| Jun 30, 2024 | 56,689.00 |
| Mar 31, 2024 | 93,155.00 |
| Dec 31, 2023 | -14,798.00 |
| Sep 30, 2023 | 103,289.00 |
| Jun 30, 2023 | -2.90 Mn |
| Mar 31, 2023 | 881,368.00 |
| Dec 31, 2022 | 809,530.00 |
| Sep 30, 2022 | 145,839.00 |
| Jun 30, 2022 | 3.53 Mn |
| Mar 31, 2022 | 53,340.00 |
| Dec 31, 2021 | 49,797.00 |
| Sep 30, 2021 | 28,532.00 |
| Jun 30, 2021 | -5.70 Mn |